Vertex Pharmaceuticals Inc
VRTX449.520USD
0.000
Close 12/17, 16:00（ET）Quotes delayed by 15 min
114.16BMarket Cap
31.42P/E TTM
Vertex Pharmaceuticals Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
11.02B
11.66%
EPS(YoY)
-2.08
-114.79%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its total revenue reached 11.02B, with a year-on-year change of 11.66%.
What is the Earnings Per Share (EPS) of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.077, with a year-on-year change of -114.79%.
What is the net income of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its net income was -535.60M, with a year-on-year change of -114.80%.
What is the net margin of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its net profit margin was -4.86%, with a year-on-year change of -113.25%.
What is the gross margin of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its gross margin was 86.11%, with a year-on-year change of -1.26%.
What is the debt-to-asset ratio of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its debt-to-asset ratio was 0.52%, with a year-on-year change of -72.10%.
What is the Return on Equity (ROE) of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its Return on Equity (ROE) was -3.15%, with a year-on-year change of -113.71%.
What is the Return on Assets (ROA) of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its Return on Assets (ROA) was -2.37%, with a year-on-year change of -113.36%.
What is the operating profit of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its operating profit was 4.39B, with a year-on-year change of 2.03%.
What are the current assets of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its current assets were 9.60B, with a year-on-year change of -32.15%.
What are the total assets of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its total assets of Vertex Pharmaceuticals Inc were 22.53B, with a year-on-year change of -0.87%.
What are the total liabilities of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its total liabilities of Vertex Pharmaceuticals Inc were 6.12B, with a year-on-year change of 18.91%.
What is the total equity of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its total equity of Vertex Pharmaceuticals Inc was 16.41B, with a year-on-year change of -6.66%.
What is the net operating income of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its net operating income of Vertex Pharmaceuticals Inc was -535.60M, with a year-on-year change of -114.80%.
What is the net investment of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its net investment of Vertex Pharmaceuticals Inc was -3.77B, with a year-on-year change of -20.00%.
What is the net financing of Vertex Pharmaceuticals Inc?
According to Vertex Pharmaceuticals Inc's FY2024 earnings report, its net financing of Vertex Pharmaceuticals Inc was -1.49B, with a year-on-year change of -165.90%.
